UMMS Affiliation

Department of Microbiology and Physiological Systems

Date

4-1-2017

Document Type

Article

Disciplines

Cancer Biology | Nanomedicine | Neoplasms | Oncology

Abstract

Engineering of this semisynthetic Salmonella nanoparticle mimic introduces a new platform technology that has the capacity to be applied to various chemotherapeutic drugs to overcome multi-drug resistance in tumors.

Rights and Permissions

© Beth A McCormick

DOI of Published Version

10.2217/nnm-2017-0005

Source

Nanomedicine (Lond). 2017 Apr;12(7):705-710. doi: 10.2217/nnm-2017-0005. Epub 2017 Mar 21. Link to article on publisher's site

Related Resources

Link to Article in PubMed

Keywords

Salmonella, cancer, drug delivery, effector proteins, multidrug resistance, nanoparticles, therapeutic adjuvant

Journal Title

Nanomedicine (London, England)

PubMed ID

28322607

Creative Commons License

Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.